Sitagliptin treatment primed monocyte differentiation towards the regenerative M2 subtype instead of the inflammatory M1 subtype and led to a reduced atherosclerosis progression (chronic vascular injury) in ApoE knockout mice [2]. This evidence concerns the gene APOE and atherosclerosis.